<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02894112</url>
  </required_header>
  <id_info>
    <org_study_id>1198</org_study_id>
    <nct_id>NCT02894112</nct_id>
  </id_info>
  <brief_title>Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal</brief_title>
  <official_title>Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dairy Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Texas at Austin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidemiological studies indicate that risk of type 2 diabetes is lower when milk is consumed
      in the regular diet. Milk products are unique in that they produce high insulin response
      despite their low glycemic index. The general aim of the proposed study is to determine the
      effect of fluid milk on attenuating the postprandial surge in plasma glucose and triglyceride
      after meals and its associated physiological mechanisms. The investigators hypothesize that
      the consumption of one or two servings of non-fat milk added to a standard oral glucose
      tolerance test (OGTT) solution or the high fat tolerance test meal will attenuate
      postprandial hyperglycemia and triglyceridemia. The investigators hypothesize that the
      postulated improvement in postprandial metabolic response due to the consumption of fluid
      milk will be associated with increased postprandial insulin secretion as well as
      insulin-mediated endothelial vasodilation and whole-limb perfusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A double blind randomized placebo-controlled crossover experimental design with six
      treatments will be used. A total of 30 young (20-40 year old) healthy men and women will
      serve as subjects. Following 2 days of physical activity and dietary control, subjects will
      consume a standard OGTT load or high fat tolerance load on the morning of Day 3. The solution
      used in the meals will be mixed with one or two servings of non-fat milk or placebo (either
      carbohydrate matched or total calorie matched). Before and after the test meals are consumed,
      blood samples will be obtained for later analysis of glucose, triglycerides, insulin, and
      inflammatory cytokines and brachial artery flow-mediated dilation and femoral artery vascular
      conductance will be measured. The present research project should provide new and clinically
      useful insight into the role of conventional dairy products on metabolic homeostasis. If the
      working hypotheses are supported, the information could be used as an initial/preliminary
      basis for recommendations for the consumption of fluid milk in the prevention of metabolic
      diseases.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood glucose</measure>
    <time_frame>2 hour postprandially</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>plasma triglyceride</measure>
    <time_frame>4 hour postprandially</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>femoral artery blood flow</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>brachial artery flow-mediated dilation</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>insulin</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>glucagon</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>GIP</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>GLP</measure>
    <time_frame>2-4 hour postprandially</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Oral Glucose Tolerance Test</condition>
  <condition>High Fat Tolerance Test</condition>
  <arm_group>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 g of glucose in a fruit punch flavored 8 oz drink</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High fat tolerance test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single high fat load determined by body weight.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>non-fat milk</intervention_name>
    <description>1 serving of non-fat fluid milk</description>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
    <arm_group_label>High fat tolerance test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>carbohydrate control beverage</intervention_name>
    <description>1 serving of carbohydrate control beverage (Carbohydrate powder + water)</description>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
    <arm_group_label>High fat tolerance test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>caloric control beverage</intervention_name>
    <description>1 serving of caloric control beverage (carbohydrate powder + protein powder + water)</description>
    <arm_group_label>Oral glucose tolerance test</arm_group_label>
    <arm_group_label>High fat tolerance test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Apparently health, sedentary. All subjects will have a BMI of 25-35 kg/m2.

        Exclusion Criteria:

          -  Candidates who are taking cardiovascular-acting drugs will not be eligible for
             participation. Subjects with significant intima-media thickening, plaque formation,
             characteristics of atherosclerosis, metabolic diseases, gastrointestinal disorders,
             and/or renal disease will be excluded from the study. Additional exclusion criteria
             will be cow milk allergy or lactose intolerance, pregnancy or lactation, and alcohol
             abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiovascular Aging Research Laboratory</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2016</study_first_submitted>
  <study_first_submitted_qc>September 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2016</study_first_posted>
  <last_update_submitted>September 2, 2016</last_update_submitted>
  <last_update_submitted_qc>September 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas at Austin</investigator_affiliation>
    <investigator_full_name>Miriam Pearman-Leary</investigator_full_name>
    <investigator_title>Doctoral Candidate</investigator_title>
  </responsible_party>
  <keyword>endothelial dependent vasodilation</keyword>
  <keyword>blood flow</keyword>
  <keyword>blood glucose</keyword>
  <keyword>triglycerides</keyword>
  <keyword>non-fat milk</keyword>
  <keyword>dairy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Hypertriglyceridemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

